Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup

por Roze, Joline, Monroe, Glen, Kutzera, Joachim, Groeneweg, Jolijn, Stelloo, Ellen, Paijens, Sterre, Nijman, Hans, van Meurs, Hannah, van Lonkhuijzen, Luc, Piek, Jurgen, Lok, Christianne, Jonges, Geertruida, Witteveen, Petronella, Verheijen, René, van Haaften, Gijs, Zweemer, Ronald
Publicado 2020

Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer

por Lubbers, Joyce M., Ważyńska, Marta A., van Rooij, Nienke, Kol, Arjan, Workel, Hagma H., Plat, Annechien, Paijens, Sterre T., Vlaming, Martijn R., Spierings, Diana C. J., Elsinga, Philip H., Bremer, Edwin, Nijman, Hans W., de Bruyn, Marco
Publicado 2022

In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors

por Roze, Joline, Sendino Garví, Elena, Stelloo, Ellen, Stangl, Christina, Sereno, Ferdinando, Duran, Karen, Groeneweg, Jolijn, Paijens, Sterre, Nijman, Hans, van Meurs, Hannah, van Lonkhuijzen, Luc, Piek, Jurgen, Lok, Christianne, Jonges, Geertruida, Witteveen, Petronella, Verheijen, René, van Haaften, Gijs, Zweemer, Ronald, Monroe, Glen
Publicado 2021

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

por Brunekreeft, Kim L., Paijens, Sterre T., Wouters, Maartje C.A., Komdeur, Fenne L., Eggink, Florine A., Lubbers, Joyce M., Workel, Hagma H., Van Der Slikke, Elisabeth C., Pröpper, Noor E.J., Leffers, Ninke, Adam, Julien, Pijper, Harry, Plat, Annechien, Kol, Arjan, Nijman, Hans W., De Bruyn, Marco
Publicado 2020

Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients

por Paijens, S. T., Vledder, A., Loiero, D., Duiker, E. W., Bart, J., Hendriks, A. M., Jalving, M., Workel, H. H., Hollema, H., Werner, N., Plat, A., Wisman, G. B. A., Yigit, R., Arts, H., Kruse, A. J., de Lange, N.M., Koelzer, V. H., de Bruyn, M., Nijman, H. W.
Publicado 2021

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

por Komdeur, Fenne L., Singh, Amrita, van de Wall, Stephanie, Meulenberg, Janneke J.M., Boerma, Annemarie, Hoogeboom, Baukje Nynke, Paijens, Sterre T., Oyarce, Cesar, de Bruyn, Marco, Schuuring, Ed, Regts, Joke, Marra, Ruben, Werner, Naomi, Sluis, Jessica, van der Zee, Ate G.J., Wilschut, Jan C., Allersma, Derk P., van Zanten, Coba J., Kosterink, Jos G.W., Jorritsma-Smit, Annelies, Yigit, Refika, Nijman, Hans W., Daemen, Toos
Publicado 2021